Answers are grounded in this paper and cite their sources.
Introduction Drug-induced liver injury (DILI) remains a challenging endpoint in predictive toxicology because molecular datasets are limited, chemical scaffolds shift across data sources, and probability scores do not necessarily indicate prediction reliability. This study aimed to develop a reliability-aware molecular screening framework for DILI prediction under chemical scaffold shift. Methods We developed CC-SCAC-AFP, which combines an AttentiveFP ranking backbone with coverage-constrained split conformal prediction and adaptive novelty-conditioned calibration. The framework was evaluated on the Therapeutics Data Commons DILI task using leakage-audited Murcko-scaffold partitions, five seeds for model comparison, and 20 four-way scaffold splits for reliability analysis. DILIst and DILIrank 2.0 were reserved for strict external evaluation. Results AttentiveFP achieved an internal mean AUROC of 0.862 (standard deviation [SD], 0.023). Across 20 reliability splits at α = 0.10, CC-SCAC-AFP achieved empirical coverage of 0.949 (SD, 0.050), compared with 0.937 (SD, 0.054) for global split conformal prediction. The corresponding mean prediction-set sizes were 1.604 and 1.521, respectively, indicating that the additional coverage was largely attributable to increased conservatism rather than improved efficiency at matched set size. On external tests, AUROC was 0.598 for both DILIst and DILIrank 2.0. Coverage was 0.891 and 0.801, respectively, below the nominal 0.90 target. The DILIrank 2.0 Brier score of 0.348 was worse than that of a constant predictor based on the observed prevalence (0.249). Discussion CC-SCAC-AFP provides a chemically indexed, set-valued reliability screening framework for early DILI molecular prioritization and makes the coverage–efficiency trade-off explicit. Two-label prediction sets identify compounds requiring further review. Because source-domain calibration did not preserve the nominal coverage target on the external datasets, recalibration in the target domain is necessary before applying the framework to a new chemical library.
No takes yet. Share an insight, caveat, or question.
Jin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: